Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

Background: Although high-risk mutations in identified major susceptibility genes (DNA mismatch repair genes and MUTYH) account for some familial aggregation of colorectal cancer, their population prevalence and the causes of the remaining familial aggregation are not known. Methods: We studied the families of 5,744 colorectal cancer cases (probands) recruited from population cancer registries in the United States, Canada, and Australia and screened probands for mutations in mismatch repair genes and MUTYH. We conducted modified segregation analyses using the cancer history of first-degree relatives, conditional on the proband's age at diagnosis. We estimated the prevalence of mutations in the identified genes, the prevalence of HR for unidentified major gene mutations, and the variance of the residual polygenic component. Results: We estimated that 1 in 279 of the population carry mutations in mismatch repair genes (MLH1 = 1 in 1,946, MSH2 = 1 in 2,841, MSH6 = 1 in 758, PMS2 = 1 in 714), 1 in 45 carry mutations in MUTYH, and 1 in 504 carry mutations associated with an average 31-fold increased risk of colorectal cancer in unidentified major genes. The estimated polygenic variance was reduced by 30% to 50% after allowing for unidentified major genes and decreased from 3.3 for age <40 years to 0.5 for age ≥70 years (equivalent to sibling relative risks of 5.1 to 1.3, respectively). Conclusions: Unidentified major genes might explain one third to one half of the missing heritability of colorectal cancer. Impact: Our findings could aid gene discovery and development of better colorectal cancer risk prediction models. Cancer Epidemiol Biomarkers Prev; 26(3); 404–12. ©2016 AACR.

[1]  P. Broderick,et al.  Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer , 2016, Nature Communications.

[2]  Aung Ko Win,et al.  Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. , 2016, Future oncology.

[3]  S. Letovsky,et al.  Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification , 2015, Genetics in Medicine.

[4]  J. Hopper,et al.  The Heritability of Prostate Cancer—Letter , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[5]  K. Smith,et al.  Familial colorectal cancer risk by subsite of primary cancer: a population‐based study in Utah , 2015, Alimentary pharmacology & therapeutics.

[6]  Christopher D. Heinen,et al.  Milestones of Lynch syndrome: 1895–2015 , 2015, Nature Reviews Cancer.

[7]  Aung Ko Win,et al.  Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. , 2014, Gastroenterology.

[8]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[9]  I. Coulson,et al.  Cowden syndrome (multiple hamartoma syndrome) , 2013, Clinical and experimental dermatology.

[10]  Peter Donnelly,et al.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.

[11]  Aung Ko Win,et al.  Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? , 2013, European journal of cancer.

[12]  G. Giles,et al.  Population-Based Estimate of Prostate Cancer Risk for Carriers of the HOXB13 Missense Mutation G84E , 2013, PloS one.

[13]  Aung Ko Win,et al.  Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers , 2012, Human mutation.

[14]  Aung Ko Win,et al.  Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Mitchell H Gail,et al.  Confirmation of family cancer history reported in a population-based survey. , 2011, Journal of the National Cancer Institute.

[16]  Aung Ko Win,et al.  Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis , 2011, Familial Cancer.

[17]  A. de la Chapelle,et al.  The Search for Unaffected Individuals with Lynch Syndrome: Do the Ends Justify the Means? , 2011, Cancer Prevention Research.

[18]  O. Dekkers,et al.  Survival of MUTYH-Associated Polyposis Patients With Colorectal Cancer and Matched Control Colorectal Cancer Patients , 2010, Journal of the National Cancer Institute.

[19]  M. Shike,et al.  Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer. , 2010, Gastroenterology.

[20]  David P. Taylor,et al.  Population-based family history-specific risks for colorectal cancer: a constellation approach. , 2010, Gastroenterology.

[21]  Finlay Macrae,et al.  Risks of Lynch syndrome cancers for MSH6 mutation carriers. , 2010, Journal of the National Cancer Institute.

[22]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[23]  J. Knight,et al.  Family history of hormonal cancers and colorectal cancer risk: A case‐control study conducted in Ontario , 2009, International journal of cancer.

[24]  John L Hopper,et al.  Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics , 2009, Human mutation.

[25]  J. Potter,et al.  Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. , 2009, Gastroenterology.

[26]  Z. Szentirmay,et al.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome , 2009, Human mutation.

[27]  A. Spurdle,et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.

[28]  J. Potter,et al.  The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. , 2008, Gastroenterology.

[29]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[30]  A. Rustgi,et al.  The genetics of hereditary colon cancer. , 2007, Genes & development.

[31]  Jukka-Pekka Mecklin,et al.  Explaining the Familial Colorectal Cancer Risk Associated with Mismatch Repair (MMR)-Deficient and MMR-Stable Tumors , 2007, Clinical Cancer Research.

[32]  John L Hopper,et al.  Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[34]  D. Bishop,et al.  After hMSH2 and hMLH1—what next? Analysis of three‐generational, population‐based, early‐onset colorectal cancer families , 2002, International journal of cancer.

[35]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[36]  J. Terdiman HNPCC: an uncommon but important diagnosis. , 2001, Gastroenterology.

[37]  L. Aaltonen,et al.  Population carrier frequency of hMSH2 and hMLH1 mutations , 2000, British Journal of Cancer.

[38]  L. Aaltonen,et al.  Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  T. Smyrk,et al.  Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members , 1998, Cancer.

[40]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1997 .

[41]  K. Lange,et al.  An approximate model of polygenic inheritance. , 1997, Genetics.

[42]  L. Aaltonen,et al.  Better survival rates in patients with MLH1-associated hereditary colorectal cancer. , 1996, Gastroenterology.

[43]  R. Elston,et al.  The finite polygenic mixed model: An alternative formulation for the mixed model of inheritance , 1994, Theoretical and Applied Genetics.

[44]  J. Carlin,et al.  Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. , 1992, American journal of epidemiology.

[45]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[46]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[47]  K. Kinzler,et al.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.

[48]  A J Krush,et al.  Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.

[49]  H. Akaike A new look at the statistical model identification , 1974 .

[50]  P. Laird,et al.  Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. , 2011, The Journal of molecular diagnostics : JMD.

[51]  S. Thibodeau,et al.  EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome , 2009, Genetics in Medicine.

[52]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[53]  A. Chapelle The Incidence of Lynch Syndrome , 2004, Familial Cancer.

[54]  R. C. Elston,et al.  Models for Discrimination Between Alternative Modes of Inheritance , 1990 .

[55]  Daniel Gianola,et al.  Advances in Statistical Methods for Genetic Improvement of Livestock , 1990, Advanced Series in Agricultural Sciences.

[56]  E. Somers International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[57]  R. Fisher XV.—The Correlation between Relatives on the Supposition of Mendelian Inheritance. , 1919, Transactions of the Royal Society of Edinburgh.

[58]  L. Penrose,et al.  THE CORRELATION BETWEEN RELATIVES ON THE SUPPOSITION OF MENDELIAN INHERITANCE , 2022 .